Cardinal Health Inc Stock Research

Market Summary

USD82.83-1.87

Market Closed

-2.21%

CAH Alerts

Big jump in Earnings (Y/Y)

CAH Stock Price

CAH RSI Chart

CAH Valuation

Market Cap

21.6B

Price/Earnings (Trailing)

46.69

Price/Sales (Trailing)

0.11

EV/EBITDA

17.24

Price/Free Cashflow

4.76

CAH Price/Sales (Trailing)

CAH Profitability

EBT Margin

-0.10%

Return on Equity

57.55%

Return on Assets

-2.86%

Free Cashflow Yield

21.02%

CAH Fundamentals

CAH Revenue

Revenue (TTM)

198.7B

Revenue Y/Y

12.6%

Revenue Q/Q

-1.91%

CAH Earnings

Earnings (TTM)

463.0M

Earnings Y/Y

124.8%

Earnings Q/Q

365.38%

Price Action

52 Week Range

48.8887.03

(Low)(High)

Last 7 days

-3.6%

Last 30 days

3.0%

Last 90 days

6.8%

Trailing 12 Months

45.2%

CAH Financial Health

Current Ratio

1.04

Debt/Equity

-2.12

Debt/Cashflow

0.68

CAH Investor Care

Dividend Yield

2.39%

Dividend/Share (TTM)

1.98

Buy Backs (1Y)

6.45%

Diluted EPS (TTM)

1.6

Peers (Alternatives to Cardinal Health)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	448.8B	335.9B	-0.30%	-2.84%	21.68	1.34	12.90%	18.65%
MCK	54.3B	276.7B	7.99%	15.32%	15.25	0.2	4.83%	219.57%
ABC	34.1B	247.5B	1.76%	8.76%	21.08	0.14	7.78%	-6.37%
CAH	21.6B	198.7B	3.04%	45.15%	46.69	0.11	12.34%	148.48%
HSIC	9.8B	12.5B	-7.75%	-12.50%	20.56	0.78	-1.00%	-26.01%
MID-CAP
LHCG	5.2B	2.3B	3.17%	35.63%	86.23	2.28	2.85%	-58.05%
HQY	4.7B	861.7M	2.36%	-9.64%	-178.64	5.42	13.90%	40.97%
AMN	3.9B	4.8B	11.84%	2.65%	10.12	0.8	3.57%	-4.88%
PDCO	2.6B	6.4B	0.49%	-14.18%	13.26	0.41	-0.52%	16.73%
SMALL-CAP
RDNT	1.7B	1.5B	6.01%	44.82%	-126.07	1.14	10.24%	-173.11%
OMI	1.6B	10.0B	39.29%	-41.00%	69.33	0.16	1.74%	-89.90%
ADUS	1.4B	976.1M	-21.09%	3.91%	28.65	1.47	10.19%	12.37%
BKD	645.6M	2.9B	-18.53%	-39.08%	-3.53	0.22	7.97%	-101.02%
PETQ	365.7M	921.5M	9.46%	-21.33%	-8.78	0.4	-1.18%	-180.05%
SMED	170.0M	-	1.98%	-1.24%	31.24	2.46	-	-

Financials for Cardinal Health

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	2.9%	198,662	193,011	186,999	181,364	176,847
Gross Profit	1.6%	6,667	6,564	6,517	6,545	6,415
S&GA Expenses	0.9%	4,722	4,680	4,640	4,557	4,531
EBITDA	417.1%	631	-199	72.00	230	-
EBITDA Margin	407.2%	0.00*	0.00*	0.00*	0.00*	-
Earnings Before Taxes	354.7%	489	-192	-1,028	-769	-622
EBT Margin	81.9%	0.00*	-0.01*	0.00*	0.00*	-
Interest Expenses	-8.2%	112	122	134	149	159
Net Income	136.4%	463	-1,273	-1,094	-933	-955
Net Income Margin	-12.7%	-0.01*	-0.01*	-0.01*	-0.01*	-
Free Cahsflow	-17.9%	2,792	3,401	2,735	446	-

Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	-2.5%	43,377	44,482	43,387	43,878	42,111
Current Assets	-3.2%	33,497	34,596	32,696	32,935	30,884
Cash Equivalents	9.2%	3,990	3,654	3,492	4,717	2,356
Inventory	-3.7%	16,620	17,263	15,891	15,636	15,493
Net PPE	0.9%	2,362	2,341	2,339	2,361	2,298
Current Liabilities	-2.1%	32,503	33,212	31,559	30,550	28,715
Long Term Debt	0.5%	4,708	4,685	4,689	4,735	4,751
Shareholder's Equity	-0.3%	-2,218	-2,212	-706	-693	-
Retained Earnings	38.9%	-342	-560	-301	-280	-281
Shares Outstanding	-3.7%	261	271	275	-	-
Minority Interest	100.0%	2.00	1.00	1.00	3.00	4.00

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	55.7%	4,973	3,193	3,791	3,122	795
Share Based Compensation	-2.3%	85.00	87.00	80.00	81.00	70.00
Cashflow From Investing	-11.6%	-452	-405	-365	567	683
Cashflow From Financing	-26.1%	-2,874	-2,280	-2,362	-2,463	-2,697
Dividend Payments	-1.5%	533	541	552	559	566
Buy Backs	3.4%	1,500	1,450	1,500	1,000	1,000

Risks for CAH

What is the probability of a big loss on CAH?

65.4%

Probability that Cardinal Health stock will be more than 20% underwater in next one year

16.9%

Probability that Cardinal Health stock will be more than 30% underwater in next one year.

Probability that Cardinal Health stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CAH drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cardinal Health was unfortunately bought at previous high price.

Drawdowns

Returns for CAH

Cumulative Returns on CAH

8.7%

10-Year Cumulative Returns

4.1%

7-Year Cumulative Returns

13.3%

5-Year Cumulative Returns

19.9%

3-Year Cumulative Returns

What are the long-term rolling returns for CAH?

FIve years rolling returns for Cardinal Health.

Annualized Returns

Which funds bought or sold CAH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-24	Old North State Trust, LLC	unchanged	-	-	10,000	0.01%
2023-05-23	Toroso Investments, LLC	added	123	1,038,000	1,904,000	0.03%
2023-05-23	Brookfield Corp /ON/	new	-	4,100,180	4,100,180	0.02%
2023-05-23	Front Row Advisors LLC	added	-	3,000	3,000	-%
2023-05-22	BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL	unchanged	-	-11,029	607,775	0.24%
2023-05-22	PUTNAM INVESTMENTS LLC	added	3.77	117,887	6,254,500	0.01%
2023-05-22	FDx Advisors, Inc.	unchanged	-	-	424,000	0.02%
2023-05-22	AMERIPRISE FINANCIAL INC	reduced	-4.88	-7,318,580	103,286,000	0.03%
2023-05-19	Coppell Advisory Solutions LLC	sold off	-100	-7,687	-	-%
2023-05-18	OLD REPUBLIC INTERNATIONAL CORP	unchanged	-	-1,159,000	63,873,000	2.04%

Latest Funds Activity

Are funds buying CAH calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own CAH

No. of Funds

CAH Alerts

Big jump in Earnings (Y/Y)

Cardinal Health News

Schedule 13G FIlings of Cardinal Health

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	price t rowe associates inc /md/	1.9%	4,994,087	SC 13G/A
Feb 09, 2023	vanguard group inc	11.95%	31,320,204	SC 13G/A
Feb 06, 2023	state street corp	6.70%	17,568,683	SC 13G/A
Jan 26, 2023	blackrock inc.	11.3%	29,572,939	SC 13G/A
Jan 20, 2023	blackrock inc.	11.3%	29,572,939	SC 13G/A
Sep 08, 2022	blackrock inc.	10.6%	28,946,151	SC 13G
Feb 14, 2022	price t rowe associates inc /md/	5.3%	15,028,767	SC 13G
Feb 10, 2022	state street corp	7.59%	21,384,169	SC 13G/A
Feb 09, 2022	vanguard group inc	12.72%	35,841,618	SC 13G/A
Feb 01, 2022	blackrock inc.	7.8%	21,999,306	SC 13G/A

CAH Fair Value

Cardinal Health fair value in different scenarios

The table shows the Fair Value estimates for Cardinal Health for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	87.64 5.81%	137.55 66.06%	253.05 205.51%	406.67 390.97%	579.72 599.89%
Current Inflation	79.79 -3.67%	123.67 49.31%	223.04 169.27%	354.51 328.00%	502.19 506.29%
Very High Inflation	71.22 -14.02%	108.43 30.91%	191.37 131.04%	299.12 261.13%	419.37 406.30%

Historical Cardinal Health Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of Cardinal Health

View All Filings

Date Filed	Form Type	Document
May 17, 2023	4	Insider Trading
May 11, 2023	8-K	Current Report
May 04, 2023	8-K	Current Report
May 04, 2023	10-Q	Quarterly Report
Mar 16, 2023	4	Insider Trading
Mar 16, 2023	4	Insider Trading
Mar 02, 2023	8-K	Current Report

Latest Insider Trading transactions for CAH

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-15	Hollar Jason M.	sold (taxes)	-257,446	84.77	-3,037	chief executive officer
2023-03-15	Mayer Jessica L	sold (taxes)	-94,481	70.72	-1,336	chief legal/compliance officer
2023-03-15	Greene Michelle D.	sold (taxes)	-47,311	70.72	-669	chief information officer
2023-02-15	Alt Aaron E	acquired	-	-	12,726	chief financial officer
2022-12-01	Snow Ola M	sold (taxes)	-47,781	80.17	-596	chief human resources officer
2022-12-01	WEITZMAN DEBORAH	sold (taxes)	-30,464	80.17	-380	ceo, pharmaceutical segment
2022-11-15	Brennan Michelle	bought	14,944	74.72	200	-
2022-11-15	Mayer Jessica L	sold (taxes)	-389,964	75.21	-5,185	chief legal/compliance officer
2022-11-14	Brennan Michelle	bought	15,260	76.3	200	-
2022-11-10	Brennan Michelle	bought	11,961	79.74	150	-

About Cardinal Health

Michael C. Kaufmann

www.cardinalhealth.com

47300

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

CAH Income Statement

2023-03-31

Condensed Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue	$ 50,487	$ 44,836	$ 151,559	$ 134,261
Cost of products sold	48,702	43,154	146,497	129,321
Gross margin	1,785	1,682	5,062	4,940
Operating expenses:
Distribution, selling, general and administrative expenses	1,179	1,137	3,567	3,402
Restructuring and employee severance	16	31	62	56
Amortization and other acquisition-related costs	74	79	216	237
Impairments and (gain)/loss on disposal of assets, net	20	471	883	1,764
Litigation (recoveries)/charges, net	(76)	61	(256)	113
Operating earnings/(loss)	572	(97)	590	(632)
Other (income)/expense, net	0	3	(5)	(14)
Interest expense, net	28	38	78	115
Loss on early extinguishment of debt	0	0	0	10
(Gain)/loss on sale of equity interest in naviHealth	0	(1)	0	(2)
Earnings/(loss) before income taxes	544	(137)	517	(741)
Provision for income taxes	197	1,253	189	328
Net earnings/(loss)	347	(1,390)	328	(1,069)
Less: Net earnings attributable to noncontrolling interests	(2)	(1)	(3)	(2)
Net earnings/(loss) attributable to Cardinal Health, Inc.	$ 345	$ (1,391)	$ 325	$ (1,071)
Earnings/(Loss) per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 1.35	$ (5.05)	$ 1.24	$ (3.82)
Diluted (in shares)	$ 1.34	$ (5.05)	$ 1.23	$ (3.82)
Weighted-average number of common shares outstanding:
Basic (in shares)	256	275	263	281
Diluted (in shares)	258	275	264	281
Cash dividends declared per common share	$ 0.4957	$ 0.4908	$ 1.4871	$ 1.4724

CAH Balance Sheet

2023-03-31

Condensed Consolidated Balance Sheets - USD ($) shares in Thousands, $ in Millions	Mar. 31, 2023	Jun. 30, 2022
Current assets:
Cash and equivalents	$ 3,990	$ 4,717
Trade receivables, net	10,992	10,561
Inventories, net	16,620	15,636
Prepaid expenses and other	1,895	2,021
Total current assets	33,497	32,935
Property and equipment, net	2,362	2,361
Goodwill and other intangibles, net	6,567	7,629
Other assets	951	953
Total assets	43,377	43,878
Current liabilities:
Accounts payable	29,601	27,128
Current portion of long-term obligations and other short-term borrowings	26	580
Other accrued liabilities	2,876	2,842
Total current liabilities	32,503	30,550
Long-term obligations, less current portion	4,708	4,735
Deferred income taxes and other liabilities	8,384	9,299
Preferred shares, without par value:
Authorized—500 thousand shares, Issued—none	0	0
Common shares, without par value:
Authorized—755 million shares, Issued—327 million shares at March 31, 2023 and June 30, 2022	2,818	2,813
Accumulated deficit	(342)	(280)
Common shares in treasury, at cost: 72 million shares and 54 million shares at March 31, 2023 and June 30, 2022, respectively	(4,554)	(3,128)
Accumulated other comprehensive loss	(142)	(114)
Total Cardinal Health, Inc. shareholders' deficit	(2,220)	(709)
Noncontrolling interests	2	3
Total shareholders’ deficit	(2,218)	(706)
Total liabilities and shareholders’ deficit	$ 43,377	$ 43,878
Preferred shares, authorized	500	500
Preferred shares, issued	0	0
Common shares, authorized	755,000	755,000
Common shares, issued	327,000	327,000
Common shares in treasury	72,000	54,000